Abstract:Background: Heterologous combinations in vaccine design are an effective approach to promote T cell activity and antiviral effects. The goal of this study was to compare the homologous and heterologous regimens targeting the Nef-Tat fusion antigen to develop a human immunodeficiency virus-1 (HIV-1) therapeutic vaccine candidate. Methods: At first, the DNA and protein constructs harboring HIV-1 Nef and the first exon of Tat as linked form (pcDNA- nef-tat and Nef-Tat protein) were prepared in large scale and high purity. The generation of the Nef-Tat protein was performed in the E. coli expression system using an IPTG inducer. Then, we evaluated and compared immune responses of homologous DNA prime/ DNA boost, homologous protein prime/ protein boost, and heterologous DNA prime/protein boost regimens in BALB/c mice. Finally, the ability of mice splenocytes to secret cytokines after exposure to single-cycle replicable (SCR) HIV-1 was compared between immunized and control groups in vitro . Results: The nef-tat gene was successfully subcloned in eukaryotic pcDNA3.1 (-) and prokaryotic pET-24a (+) expression vectors. The recombinant Nef-Tat protein was generated in the E. coli Rosetta strain under optimized conditions as a clear band of ~ 35 kDa detected on SDS-PAGE. Moreover, transfection of pcDNA- nef-tat into HEK-293T cells was successfully performed using Lipofectamine 2000, as confirmed by western blotting. The immunization studies showed that heterologous DNA prime/protein boost regimen could significantly elicit the highest levels of Ig- G2a, IFN-γ, and Granzyme B in mice as compared to homologous DNA/DNA and protein/protein regimens. Moreover, the secretion of IFN-γ was higher in DNA/protein regimens than in DNA/DNA and protein/protein regimens after exposure of mice splenocytes to SCR HIV-1 in vitro . Conclusion: The chimeric HIV-1 Nef-Tat antigen was highly immunogenic, especially when applied in a heterologous prime/ boost regimen. This regimen could direct immune response toward cellular immunity (Th1 and CTL activity) and increase IFN-γ secretion after virus exposure.

Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients.

Antibodies to Thenefprotein and Tonefpeptides in HIV-1—Infected Seronegative Individuals

Short Communication: in VitroSynergy Between Peptides or Neutralizing Antibodies Targeting the N- and C-Terminal Heptad Repeats of HIV Type 1 Gp41

Production of A Nonfunctional Nef Protein in Human-Immunodeficiency-Virus Type-1-Infected Cem Cells

Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: The envelope of the human immunodeficiency virus (HIV-1)

Preparation and Identification of Recombinant HIV-1 CN54 Nef Antigen

Antibody Responses of Chimpanzees Immunized with Synthetic Peptides Corresponding to Full-Length V3 Hypervariable Loops of HIV-1 Envelope Glycoproteins.

The Serum Levels and Roles of Regulated Upon Activation Normal T Cell Expressed and Secreted and Monocyte Chemoattractant Protein-1 in Human Immunodeficiency Virus-1 Infected Patients

Replicating Ad-recombinants Encoding Non-Myristoylated Rather Than Wild-Type HIV Nef Elicit Enhanced Cellular Immunity

Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects

Enhancement of Human Immunodeficiency Virus Type 1 Infection by Antisera to Peptides from the Envelope Glycoproteins Gp120/gp41.

Study of the Cyclic Peptide Binding to HIV-1 Gp41 NHR

Antibodies to HIV-1 Gp41 Recognize Synthetic Peptides of Human IFN-α and IFN-β

Identification of Novel Subcellular Localization and Trafficking of HIV-1 Nef Variants from Reference Strains G (F1.93.HH8793) and H (BE.93.VI997)

Production and characterization of human monoclonal antibodies against core protein p25 and transmembrane glycoprotein gp41 of HIV-1.

Prokaryotic Expression and Purification of HIV-1 Vif and Hapobec3g, Preparation of Polyclonal Antibodies

PEPTIDES HAVING IMMUNOLOGICAL PROPERTIES 2 HIV 2

Detection of Antibodies Against the African Parasite Using Synthetic glycosylphosphatidylinositol oligosaccharide fragments

Development and Identification of Polyclonal Antibodies Against HIV-1 Vprderived Polypeptides

Detection of Anti-Scl-70 Antibody by Recombinant Fusion Peptide Enzyme-Linked Immunosorbent Assay: a Preliminary Study

Expression and Purification of Gp41-Gp36 Fusion Protein and Application in Serological Screening Assay of HIV-1 and HIV-2